Medadvisor Share Price and Company Fundamentals
Last traded: Last Friday at 5:45 AM
MedAdvisor Limited, together with its subsidiaries, develops and delivers software for personal medication management in Australia, the United States, the United Kingdom, and Asia. It develops and deploys the MedAdvisor, a medication and adherence platform that supports and empowers individuals and carers to manage all aspects of prescription medication using mobile and web apps. MedAdvisor Limited was incorporated in 2010 and is headquartered in Camberwell, Australia.
|Primary activities||E-healthcare software developer|
|Industry / Sector||Health Information Services / Healthcare|
|Mailing address||971 Burke Road Level 2 Camberwell VIC 3124 Australia|
|Phone / Fax||61 3 9095 3036 / 61 3 9882 3317|
|Share registry||COMPUTERSHARE INVESTOR SERVICES PTY LIMITED|
Medadvisor does not pay dividends.
As of Sep 2021, following are the company executives and directors listed on Medadvisor.
|Mr. Robert Read BComm(Mgt), BA(Psych), GAICD||MD, CEO & Exec. Director||313.12k|
|Mr. Joshua Swinnerton MEI, GradCert Eng., BE, BCS(Hons).||Founder, Chief Product Officer & Exec. Director||282.7k|
|Mr. Simon Glover||Chief Financial Officer||216.94k|
|Mr. Craig Schnuriger||Interim Chief Technology Officer|
|Ms. Naomi Lawrie||Company Sec. & Gen. Counsel|
|Jennifer Duraisingam||Corp. Communications Mang.|
|Ms. Ruba El-Afifi||Exec. Gen. Mang. of People & Culture|
|Mr. Jamal Butt||Head of Commercial|
|Mr. Keith Kiarsis||Pres & CEO of the US business|
|Mr. Steve Watt||Chief Revenue Officer|
Profitability and management effectiveness
Return on assets
Return on equity
Profitability ratios are a class of financial metrics that are used to assess a business's ability to generate earnings relative to its revenue, operating costs, balance sheet assets, and shareholders' equity over time, using data from a specific point in time.
The return on equity signifies how well the management is running the company in terms of capital management. The ideal return on equity is greater than 10%. The return on equity is calculated as net income divided by total share holders equity.
Valuation and Trading Info
The market capitalization of Medadvisor is 117M and its enterprise value is 119.39M. The enterprise value to revenue ratio of MDR is 3.08.
The MDR's stocks Beta value is 0.10 making it 90% less volatile compared to ASX market index. Technology stocks and small caps tend to have higher betas than the market benchmark. This indicates that adding the stock to a portfolio will increase the portfolio’s risk, but also increase its expected return. On the other hand utility stocks often have low betas because they tend to move more slowly than market averages.
Companies similar to Medadvisor (MDR)
- Ansell (ANN)
- Cochlear (COH)
- Estia Health (EHE)
- Fisher & Paykel Healthcare Corporation (FPH)
- Healius (HLS)
- Nanosonics (NAN)
- Polynovo (PNV)
- Pro Medicus (PME)
- Ramsay Health Care (RHC)
- Resmed Inc (RMD)
- Sonic Healthcare (SHL)
Medadvisor (ASX:MDR) Frequently Asked Questions
1. What is Medadvisor's Stock Symbol?
Medadvisor trades on ASX under the ticker symbol "MDR".
2. What is Medadvisor's stock price today?
One share of MDR stock can currently be purchased for approximately $0.31.
3. How can I contact Medadvisor?
Medadvisor's mailing address is 971 Burke Road Level 2 Camberwell VIC 3124 Australia. The company can be reached via phone at 61 3 9095 3036.
4. What is Medadvisor's official website?
The official website of Medadvisor is http://www.medadvisor.com.au.
5. Which share registry manages Medadvisor's stock?
Medadvisor's stock is managed by COMPUTERSHARE INVESTOR SERVICES PTY LIMITED.